Tecovirimat Completed Phase 3 Trials for Variola Major (Smallpox) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04971109Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Day
NCT02474589A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat